Valuation: Electromed, Inc.

Market Cap 350M 307M 283M 264M 497M 33.12B 506M 3.39B 1.32B 16.34B 1.32B 1.29B 56.93B P/E 2026 *
34.8x
P/E 2027 * 28.6x
Enterprise Value 350M 307M 283M 264M 497M 33.12B 506M 3.39B 1.32B 16.34B 1.32B 1.29B 56.93B EV / Sales 2026 *
4.76x
EV / Sales 2027 * 4.19x
Free-Float
78.56%
Yield 2026 *
-
Yield 2027 * -
1 day+0.17%
1 week+9.78%
1 month+12.14%
3 months+80.69%
6 months+45.26%
Current year+45.26%
1 week 38.48
Extreme 38.4801
43.05
1 month 35.61
Extreme 35.61
43.05
Current year 23.01
Extreme 23.01
43.05
1 year 17.73
Extreme 17.73
43.05
3 years 8.8
Extreme 8.8
43.05
5 years 8.75
Extreme 8.75
43.05
10 years 3.38
Extreme 3.38
43.05
Manager TitleAgeSince
Chief Executive Officer 61 30/06/2023
Director of Finance/CFO 44 13/11/2022
Compliance Officer - 31/08/2023
Director TitleAgeSince
Chairman 69 30/06/2023
Director/Board Member 76 20/11/2014
Director/Board Member 57 14/08/2019
Date Insider Type Main position Quantity % Market Cap.
06-07Fiscal year

Chief Executive Officer

29,100 0.3514%
06-03Fiscal year

Chief Financial Officer

31,003 0.3744%
05-14Fiscal year

Chairman

120,000 1.4501%
Change 5-day change 1-year change 3-year change Capi.($)
+0.17%+9.78%+92.36%+294.96% 350M
-1.00%+6.82%+23.65%-3.91% 186B
-2.04%-1.36%-26.82%+16.30% 141B
-1.19%+6.43%-3.57%-20.63% 135B
-1.84%-6.40%-60.26%-21.09% 63.44B
-0.79%+4.04%+15.66%-4.10% 52.09B
+0.41%-0.93%-27.33%-34.05% 43.6B
+0.19%+4.86%+12.56%+10.46% 37.52B
+1.67%+4.99%+7.45%+40.71% 36.82B
-1.60%+0.46%-13.58%-21.21% 29.12B
Average -0.60%+3.31%+2.01%+25.74% 72.49B
Weighted average by Cap. -1.04%+3.86%-5.06%-3.96%

Financials

2026 *2027 *
Net sales 73.6M 64.42M 59.47M 55.47M 105M 6.96B 106M 713M 277M 3.43B 277M 270M 11.96B 83.6M 73.18M 67.55M 63.01M 119M 7.9B 121M 810M 315M 3.9B 314M 307M 13.59B
Net income 10.53M 9.22M 8.51M 7.94M 14.96M 996M 15.23M 102M 39.63M 491M 39.57M 38.69M 1.71B 12.83M 11.23M 10.37M 9.67M 18.22M 1.21B 18.55M 124M 48.29M 599M 48.21M 47.14M 2.09B
Net Debt - -
Logo Electromed, Inc.
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Employees
179
Date Price Change Volume
30/06/26 US$42.30 +0.17% 160,430
29/06/26 US$42.23 +1.86% 97,113
26/06/26 US$41.46 +3.52% 201,127
25/06/26 US$40.05 +2.38% 89,093
24/06/26 US$39.12 +1.53% 152,542
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
42.30USD
Average target price
40.33USD
Spread / Average Target
-4.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ELMD Stock